Skip to content
Care Health Insurance logo
Pre-IPOPublic Limited

Care Health Insurance Unlisted Share Price

Care Health Insurance Ltd

Financial Services·Insurance

CIN
U66000DL2007PLC161503
ISIN
INE119J01011
Incorporated
2 Apr 2007
Registered state
Delhi

Key valuation

Market cap
₹15,138 Cr
P/E
1240.8x
Debt / equity
0.0x
Shares outstanding
99,59,21,053

Indicative price

₹152prev ₹152

1M

+9.35%

6M

+28.81%

1Yr

-1.94%

Max

-16.48%

Updated 17 Nov 2026, 08:10

Prices shown are indicative, dealer-quoted and updated periodically — they are not exchange-traded prices and may differ from the price at which a transaction is finally executed.

Price history

Dated dealer-quote averages, plotted on a true time scale. There is no continuous trading behind these numbers.

-1.94%since 17 Nov 2025High ₹158Low ₹118321 dated snapshots

About Care Health Insurance

Care Health Insurance Limited, formerly Religare Health Insurance, is a standalone health insurer incorporated in 2007 and a subsidiary of Religare Enterprises Limited. Unlike general insurers, it sells only health-related cover.

Its products for individuals, families and companies include health insurance, top-up cover, personal accident, maternity, international travel and critical illness plans, along with group health and group accident cover, about 18 products in all. The company has around 110 branches and a network of more than 9,450 hospitals across India.

Care Health reported a net worth of ₹2,666 crore for FY2026. The revenue and profit figures in our data for FY2026 (₹38 crore and ₹12 crore) look incomplete and are being checked.

Key highlights

  • Incorporated in 2007

Financial snapshot

FY2026

Revenue FY2026
₹38.00 Cr
EBITDA
₹17.80 Cr
PAT
₹12.20 Cr
Net worth
₹2,666.40 Cr
Total debt
₹100.00 Cr
Cash & equivalents
—
Operating cash flow
₹0.00 Cr
EPS
₹0.12

Management & board

  • AK

    Abhay Kumar Agarwal

    Director

    Since 2025
  • AL

    Arjun Lamba

    Director

    Since 2025
  • SS

    Sunish Sharma

    Director

    Since 2021
  • UG

    Upma Goel

    Additional Director

    Since 2026
  • SM

    Suresh Mahalingam

    Director

    Since 2025
  • PK

    Praveen Kumar Tripathi

    Director

    Since 2022
  • RB

    Rishiraj Bharatprakash Khajanchi

    Director

    Since 2024
  • MK

    Malay Kumar Sinha

    Director

    Since 2018
  • NC

    Nirmal Chand

    Director

    Since 2024
  • GR

    Gurumurthy Ramanathan

    Director

    Since 2025
  • BS

    Biju Sushama Vasudevan

    Nominee Director

    Since 2024
  • AK

    Ajay Kumar Shah

    Additional Director, Managing Director, CEO

    Since 2026
  • MV

    Manish Vishnu Dodeja

    Whole-time director

    Since 2026

Reported financials · FY2022–FY2026

Figures in ₹ crore unless stated.

Revenue CAGR -42.2%PAT CAGR 1.5%
ParticularsFY2022FY2023FY2024FY2025FY2026YoYCAGR
Profit & loss
Revenue from operationsYoY -82.8%CAGR -42.2%34174949922138-82.8%-42.2%
Other incomeYoY -5.0%CAGR —00022-5.0%—
Total expensesYoY +46.4%CAGR -49.0%326421891522+46.4%-49.0%
EBITDAYoY -91.5%CAGR +3.4%1632841020818-91.5%+3.4%
Depreciation & amortisation00000——
EBITYoY -91.5%CAGR +3.4%1632841020818-91.5%+3.4%
Finance cost00000——
Profit before taxYoY -91.5%CAGR +3.4%1632841020818-91.5%+3.4%
Tax expenseYoY -89.2%CAGR +8.6%482105536-89.2%+8.6%
Profit after taxYoY -92.1%CAGR +1.5%1224630515512-92.1%+1.5%
Earnings per shareYoY -92.3%CAGR 0.0%₹0.12₹2.47₹3.06₹1.56₹0.12-92.3%0.0%
Balance sheet
Net worthYoY +14.4%CAGR +41.4%—9429722,3312,666+14.4%+41.4%
Total debt0000100——
Current liabilitiesYoY +14.7%CAGR +3.5%3,3063,7934,2153,3063,793+14.7%+3.5%
Current assets8,47711,00813,450-6,105-8,265——
Total assetsYoY +15.6%CAGR +20.8%1,2891,7442,1982,3722,743+15.6%+20.8%
Cash flow
Operating activities11418624600——
Investing activities-99-154-21100——
Financing activities-12-28-3200——
Free cash flow9616221800——
Net change in cash34300——

YoY compares the latest year with the one before it. CAGR runs from the oldest reported year to the latest. A dash means the year is missing, or the starting figure is zero or negative, so a percentage would mislead.

Margins, returns, liquidity, leverage and every other ratio from these figures: see Ratios

Revenue, EBITDA and PAT

₹ crore. A year with no reported figure is left out rather than drawn as zero.

0187374562749FY2022 · Revenue: 341FY2022 · EBITDA: 16FY2022 · PAT: 12FY2022FY2023 · Revenue: 749FY2023 · EBITDA: 328FY2023 · PAT: 246FY2023FY2024 · Revenue: 499FY2024 · EBITDA: 410FY2024 · PAT: 305FY2024FY2025 · Revenue: 221FY2025 · EBITDA: 208FY2025 · PAT: 155FY2025FY2026 · Revenue: 38FY2026 · EBITDA: 18FY2026 · PAT: 12FY2026
0187374562749FY2022 · Revenue: 341FY2022 · EBITDA: 16FY2022 · PAT: 12FY2022FY2023 · Revenue: 749FY2023 · EBITDA: 328FY2023 · PAT: 246FY2023FY2024 · Revenue: 499FY2024 · EBITDA: 410FY2024 · PAT: 305FY2024FY2025 · Revenue: 221FY2025 · EBITDA: 208FY2025 · PAT: 155FY2025FY2026 · Revenue: 38FY2026 · EBITDA: 18FY2026 · PAT: 12FY2026
  • Revenue
  • EBITDA
  • PAT

Every ratio here is worked out from the reported figures in the Financials tab, and valuation multiples from the indicative price in the header. Nothing is a stored value. A ratio the filings cannot support (a line not reported, or a zero or negative base) is left out or shown as —, never as a misleading number. Balance-sheet ratios use year-end figures.

Valuation multiples

What the indicative price pays for the latest year's earnings, book and cash. On FY2026 figures and the ₹152 indicative price.

Market cap
₹15,138 Cr
Enterprise value
₹15,238 Cr
Price / earnings (P/E)
1240.82x
Price / book (P/B)
5.68x
Price / sales (P/S)
398.37x
EV / EBITDA
856.07x
EV / EBIT
856.07x
EV / sales
401.00x
Earnings yield
0.1%
Free cash flow yield
0.0%
How these are worked out
Market cap
Indicative price × shares outstanding
Enterprise value
Market cap + debt − cash
Price / earnings (P/E)
Market cap ÷ PAT (profitable years only)
Price / book (P/B)
Market cap ÷ net worth
Price / sales (P/S)
Market cap ÷ revenue from operations
EV / EBITDA
Enterprise value ÷ EBITDA
EV / EBIT
Enterprise value ÷ (EBITDA − depreciation)
EV / sales
Enterprise value ÷ revenue from operations
Earnings yield
PAT ÷ market cap
Free cash flow yield
(Operating cash flow − capex) ÷ market cap

Shareholding pattern

Latest disclosed. The source does not state a date.

Largest holder: Religare Enterprises Limited 62.84%

62.8%15.8%16.1%

IPO / listing status

Pre-IPONot yet announced

The company has not announced IPO details such as a DRHP filing, an expected window or its bankers. This section will update once it does.

Research & news

Information currently unavailable

Nothing has been published on Care Health Insurance yet. Research, news and articles tagged with it will appear here when they are.

Browse all research

Documents

Private documents are shown locked and are released to verified clients on request.

DocumentTypeFY / dateAccess
Financial Statements FY 2025-26Financials · FY 2025-26 · 1.3 MB1.3 MBFinancialsFY 2025-26ViewDownload
Annual Report FY 2023-24Annual report · FY 2023-24 · 7.3 MB7.3 MBAnnual reportFY 2023-24ViewDownload
Annual Report FY 2022-23Annual report · FY 2022-23 · 2.0 MB2.0 MBAnnual reportFY 2022-23ViewDownload
Annual Report FY 2021-22Annual report · FY 2021-22 · 10.6 MB10.6 MBAnnual reportFY 2021-22ViewDownload
Annual Report FY 2020-21Annual report · FY 2020-21 · 10.5 MB10.5 MBAnnual reportFY 2020-21ViewDownload
Annual Report FY 2019-20Annual report · FY 2019-20 · 4.4 MB4.4 MBAnnual reportFY 2019-20ViewDownload
Annual Report FY 2018-19Annual report · FY 2018-19 · 6.0 MB6.0 MBAnnual reportFY 2018-19ViewDownload

Care Health Insurance unlisted shares: FAQs

What is the Care Health Insurance unlisted share price today?

The indicative price of Care Health Insurance Ltd shares is ₹152 per share, as of 17 Nov 2026. Unlisted shares have no exchange price: this figure reflects recent off-market deals and can differ from the price on a particular trade. The price history on this page shows how it has moved.

How can I buy Care Health Insurance unlisted shares?

Raise a buy enquiry on this page with the number of shares you want. Our desk confirms availability and the price, you pay from a bank account in your own name, and the shares are transferred to your demat account. You need a PAN and a demat account with any depository participant.

How can I sell Care Health Insurance shares?

Raise a sell enquiry with the number of shares you hold in demat. Once the price is agreed, you transfer the shares from your demat account and the money is paid to a bank account in your name.

Is Care Health Insurance planning an IPO?

Care Health Insurance Ltd is currently at the "Pre-IPO" stage. No IPO date has been announced. A listing depends on the company and on regulatory approval.

What are Care Health Insurance's revenue and profit?

In FY26, Care Health Insurance Ltd reported revenue of ₹38 Cr and a profit of ₹12 Cr, with a net worth of ₹2,666 Cr. The Financials section has the full statements for every year we hold.

Is it legal to buy unlisted shares in India?

Yes. Shares of unlisted public companies can be bought and sold off-market and transferred between demat accounts. They carry more risk than listed shares: prices are not set on an exchange, it can take time to find a buyer, and a listing is never guaranteed.

Is there a lock-in on Care Health Insurance shares after the IPO?

SEBI rules lock in shares held before an IPO for a period after listing, currently six months from allotment for most investors in a mainboard IPO. Shares bought now in the unlisted market would usually be covered by this lock-in.

How are gains on Care Health Insurance unlisted shares taxed?

Gains on unlisted shares held for more than 24 months are long-term capital gains; held for less, they are short-term and taxed at your slab rate. Check the current rates with a tax adviser before you sell.